News Focus
News Focus
Followers 1354
Posts 274156
Boards Moderated 53
Alias Born 12/07/2009

Re: None

Tuesday, 02/06/2024 12:01:41 PM

Tuesday, February 06, 2024 12:01:41 PM

Post# of 2379526
$NBIO Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued

Marble Arch Research suggests Nascent Value at $0.60 to $2.84 per share

The report can be viewed on the Company web site at: https://nascentbiotech.com/marble-arch-research-what-is-pritumumab-and-how-it-works/

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today